Semax Made in USA — Third-Party Verified
PX1 Research supplies high-grade synthetic Semax manufactured strictly within United States facilities to guarantee uncompromising molecular integrity for advanced laboratory applications. Every lot undergoes rigorous third-party analytical testing, including HPLC purity profiling, ESI-MS mass identification, and LAL endotoxin quantification in ISO 17025 accredited facilities. Designed exclusively for in vitro assay systems and preclinical rodent models, our domestically synthesized Semax sets the industry standard for academic and enterprise research.
Quick answer
PX1 Research supplies high-grade synthetic Semax manufactured strictly within United States facilities to guarantee uncompromising molecular integrity for advanced laboratory applications. Every lot undergoes rigorous third-party analytical testing, including HPLC purity profiling, ESI-MS mass identification, and LAL endotoxin quantification in ISO 17025 accredited facilities. Designed exclusively for in vitro assay systems and preclinical rodent models, our domestically synthesized Semax sets the industry standard for academic and enterprise research.
Key takeaways
- [Semax](/research-peptides/semax) is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH), specifically the ACTH(4-10) sequence, stabilized with a C-terminal Pro-Gly-Pro tripeptide motif.
- The supply chain for biochemical reagents often suffers from inconsistent synthesis protocols, residual heavy metal contamination, and degraded product purity due to extended overseas transit times and unmonitored thermal fluctuations.
- To satisfy the rigorous standards of modern academic and pharmaceutical research, every lot of [Semax](/research-peptides/semax) manufactured for PX1 Research undergoes exhaustive analytical characterization.
- Bacterial endotoxins, primarily lipopolysaccharides (LPS) derived from Gram-negative outer membranes, pose a significant risk to in vitro and preclinical experimental validity.
Chemical Architecture and Molecular Specifications of Semax
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH), specifically the ACTH(4-10) sequence, stabilized with a C-terminal Pro-Gly-Pro tripeptide motif. Its full primary amino acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro, yielding a nominal molecular weight of approximately 809.9 g/mol. The incorporation of the C-terminal tripeptide extension dramatically enhances enzymatic resistance, protecting the peptide core against rapid degradation by serum peptidases and carboxypeptidases during in vitro cell culture and preclinical vivo administration.
When evaluating Semax made in USA, researchers gain access to a peptide synthesized with precise stereochemical control, ensuring that all amino acid residues retain their correct L-conformation. This structural exactness is vital when mapping receptor interaction kinetics or gene expression cascades in laboratory models. The synthetic stabilization allows investigators to study prolonged signaling downstream of melanocortin receptors without the confounders associated with ultra-short endopeptidase cleavage native to unmodified peptide sequences. Detailed documentation on peptide sequence verification and structural integrity is available within our comprehensive research library.
The Strategic Imperative: Why Domestic USA Synthesis Matters
The supply chain for biochemical reagents often suffers from inconsistent synthesis protocols, residual heavy metal contamination, and degraded product purity due to extended overseas transit times and unmonitored thermal fluctuations. Procurement of research peptides synthesized within the United States mitigates these technical vulnerabilities. PX1 Research utilizes domestic Solid-Phase Peptide Synthesis (SPPS) methodologies operating within state-of-the-art, cGMP-compliant facilities across California and Arizona.
Domestic manufacturing enforces stringent regulatory oversight at every production stage—from raw amino acid monomer verification to final trifluoroacetate (TFA) salt exchange. Sourcing high-purity Semax made in USA eliminates batch-to-batch variance commonly observed in imported reagents, providing institutional researchers with reliable, reproducible data across multi-phase experimental designs. Furthermore, domestic fulfillment ensures immediate dispatch from our CA and AZ facilities, with same-day shipping available Monday through Friday to prevent degradation caused by transit delays.
Comprehensive Analytical Testing: HPLC, ESI-MS, and Lot-Specific COAs
To satisfy the rigorous standards of modern academic and pharmaceutical research, every lot of Semax manufactured for PX1 Research undergoes exhaustive analytical characterization. High-Performance Liquid Chromatography (HPLC) is employed to assess chromatographic purity, utilizing reverse-phase C18 analytical columns with gradient elution profiles (typically water/acetonitrile containing 0.1% TFA). Our release criteria mandate a minimum purity threshold of ≥98.0%, with primary analytical peak integration clearly separated from minor deletion sequences or diastereomeric impurities.
Identity confirmation is simultaneously established using Electrospray Ionization Mass Spectrometry (ESI-MS). The resulting mass spectrum must exhibit single or doubly charged molecular ions matching the theoretical monoisotopic mass of the peptide (m/z [M+H]+ = 810.9). Each batch is accompanied by an unedited, lot-specific Certificate of Analysis (COA) directly generated by an independent, ISO 17025 accredited testing facility. Researchers can review these analytical assays to verify peptide concentration, purity profiles, and structural authenticity prior to reconstituting reagents for experimental protocols.
Endotoxin Quantitation and Bioburden Controls for In Vitro Assay Validity
Bacterial endotoxins, primarily lipopolysaccharides (LPS) derived from Gram-negative outer membranes, pose a significant risk to in vitro and preclinical experimental validity. In neuronal tissue cultures, endothelial models, and primary cell lines, even trace amounts of LPS can trigger unwanted inflammatory cascades, upregulating NF-κB pathways and distorting baseline transcriptomic data. To ensure experimental cleanroom conditions, PX1 Research subjects all peptide lots to quantitative chromogenic Limulus Amebocyte Lysate (LAL) testing.
Our internal quality limits enforce strict endotoxin thresholds (typically <0.01 EU/mg), vastly superior to standard commercial peptide preparations. By rigorously clearing bioburden and synthetic residues, our laboratory-grade research peptides allow investigators to attribute observed cellular shifts—such as neurotrophic factor elevation or neuroprotective signaling—solely to the active Semax molecule rather than background endotoxin artifacts.
Primary Mechanisms: Brain-Derived Neurotrophic Factor (BDNF) Upregulation
Preclinical studies indicate that Semax acts as a potent modulator of neurotrophin expression within central nervous system tissue models. In rodent hippocampal and cortical tissue preparations, exposure to Semax has been shown to rapidly induce transcriptional activity of the *Bdnf* gene, resulting in elevated levels of mature Brain-Derived Neurotrophic Factor (BDNF) protein alongside its primary receptor, Tropomyosin receptor kinase B (TrkB). This neurotrophin axis plays a foundational role in synaptic plasticity, dendritic spine remodeling, and long-term potentiation (LTP) protocols.
In vitro data indicate that the heptapeptide additionally influences Nerve Growth Factor (NGF) transcript levels, demonstrating a selective regulatory effect on neurotrophic networks without displaying direct agonist activity at classic opioid receptors. Researchers investigating neuroplasticity pathways utilize Semax to dissect the intracellular signaling cascades downstream of TrkB activation, including extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)/Akt pathways in cultured primary neurons.
Cerebrovascular and Gene Expression Profiling in Preclinical Models
Beyond neurotrophin regulation, preclinical animal models of focal cerebral ischemia suggest that Semax exerts pronounced neuroprotective and vasoactive properties. High-throughput mRNA sequencing of ischemic brain tissue treated with Semax reveals significant down-regulation of genes implicated in inflammatory cascades (such as IL-1β, IL-6, and TNF-α) alongside concurrent up-regulation of genes regulating vascular endothelial growth factor (VEGF) and extracellular matrix stabilization.
Laboratory studies further suggest that Semax modulates monoaminergic systems within the striatum and hypothalamus. Rodent microdialysis assays demonstrate altered turnover rates of dopamine and serotonin following peptide exposure, pointing toward a secondary neuromodulatory mechanism. These multifaceted actions make Semax an valuable probe for researching multi-target interventions in models of hypoxic-ischemic neuronal injury and neurodegenerative pathology.
Comparative Analysis: Semax vs. Selank vs. Dihexa vs. Noopept
When designing neurobiological and cognitive research paradigms, investigators often evaluate Semax alongside other established synthetic neuroactive compounds. A comparative assessment highlights distinct molecular targets across these structural classes. While Semax is an ACTH(4-10) analog focused primarily on BDNF/TrkB axis elevation and cerebrovascular gene modulation, Selank is a synthetic analog of the immunomodulatory peptide tuftsin, designed to modulate enkephalin degradation and GABAergic neurotransmission in stress-response models.
Conversely, non-peptide and peptidomimetic agents offer contrasting pharmacokinetic and pharmacodynamic profiles. For instance, Dihexa is an oligopeptide derivative engineered for high-affinity binding to Hepatocyte Growth Factor (HGF) and its receptor c-Met to induce robust synaptogenesis. Meanwhile, Noopept functions as a proline-containing dipeptide ester derivative that influences AMPA and cholinergic receptor expression. Evaluating these compounds side-by-side in vitro allows laboratories to map non-overlapping neuroprotective, synaptogenic, and anxiolytic pathways across distinct experimental cohorts.
Reconstitution Protocols and Laboratory Storage Guidelines
Proper handling and storage protocols are critical to preserving the primary structure and biological activity of lyophilized Semax. Upon receipt, the lyophilized peptide cake should be stored in a dark, desiccated environment at -20°C for short-term preservation, or -80°C for long-term storage. Exposure to room temperature should be minimized during initial inventory cataloging.
For laboratory reconstitution, researchers should reconstitute the lyophilized powder using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4), depending on downstream cell culture compatibility. Reconstitution should be performed by gently introducing the solvent along the inner glass wall of the vial, followed by gentle swirling; aggressive vortexing must be strictly avoided to prevent physical shear stress and peptide aggregation. Once reconstituted, liquid aliquots should be frozen at -20°C to eliminate repeated freeze-thaw cycles that can induce peptide cleavage or oxidation of the N-terminal methionine residue.
Institutional Sourcing & Enterprise Wholesale Supply Chains
Academic laboratories, contract research organizations (CROs), and biotechnology firms require consistent supply chain predictability to sustain multi-year research initiatives. Variations in peptide lot purity or unexpected stock outages can compromise ongoing experimental timelines and invalidate comparative longitudinal datasets. PX1 Research provides institutional accounts with direct access to consistent, large-batch manufacturing runs to safeguard experimental continuity.
Through our wholesale research accounts, principal investigators and procurement officers can secure dedicated production batches with matching analytical profiles across multi-gram quantities. Supported by redundant fulfillment centers in California and Arizona, PX1 Research guarantees rapid turnaround, comprehensive compliance documentation, and direct technical support from our analytical chemistry team to support complex research inquiries.
Frequently Asked Questions
Where is PX1 Research Semax synthesized?
All Semax supplied by PX1 Research is synthesized within the United States in cGMP-compliant manufacturing facilities. We do not import crude peptide bases or reliance on unverified overseas supply chains.
What analytical methodologies are used to verify Semax purity?
Every lot of Semax undergoes High-Performance Liquid Chromatography (HPLC) to verify chromatographic purity (≥98.0%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm precise molecular mass (809.9 g/mol).
How can researchers verify the analytical results for a specific batch?
A lot-specific Certificate of Analysis (COA) generated by an independent, ISO 17025 accredited laboratory is provided with every shipment and is accessible directly through our online verification portal.
What is the endotoxin limit for PX1 Research Semax?
PX1 Research enforces strict bioburden controls, utilizing Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below 0.01 EU/mg, making it ideal for sensitive in vitro assays and cell culture systems.
What solvent is recommended for reconstituting Semax in laboratory assays?
Semax is readily soluble in aqueous solutions. For standard non-cellular assays, sterile Bacteriostatic Water is recommended. For cell culture experiments sensitive to preservatives, sterile 0.9% Normal Saline or PBS (pH 7.4) should be used.
What are the primary molecular targets studied with Semax in preclinical research?
Preclinical research primarily focuses on Semax's modulation of the BDNF/TrkB pathway, NGF gene expression, melanocortin receptor interactions, and gene networks regulating cerebrovascular inflammatory responses.
How should lyophilized and reconstituted Semax be stored?
Lyophilized Semax should be stored at -20°C or -80°C upon receipt. Once reconstituted into liquid solution, aliquots should be kept at -20°C to prevent hydrolysis and avoid repeated freeze-thaw cycles.
What are the dispatch and delivery timelines for research orders?
Orders placed before cutoff times ship same-day, Monday through Friday, operating directly out of our domestic fulfillment hubs located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.